Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.



<ul>
<li>Piper Sandler cut HubSpot Inc (NYSE:HUBS) price target from $400 to $280. Piper Sandler analyst Billy Fitzsimmons maintained an Overweight rating. HubSpot shares closed at $209.33 on Wednesday. See how other analysts view this stock.</li>



<li>Exane BNP Paribas raised the price target for Ecolab Inc (NYSE:ECL) from $330 to $345. Exane BNP Paribas analyst Seth Weber reiterated an Outperform rating. Ecolab shares closed at $303.55 on Wednesday. See how other analysts view this stock.</li>



<li>Benchmark boosted Tower Semiconductor Ltd (NASDAQ:TSEM) price target from $150 to $165. Benchmark analyst Cody Acree maintained a Buy rating. Tower Semiconductor shares closed at $134.44 on Wednesday. See how other analysts view this stock.</li>



<li>Baird slashed the price target for Inspire Medical Systems Inc (NYSE:INSP) from $130 to $74. Baird analyst Mike Polark downgraded the stock from Outperform to Neutral. Inspire Medical shares closed at $68.21 on Wednesday. See how other analysts view this stock.</li>



<li>BTIG cut the price target for Unity Software Inc (NYSE:U) from $60 to $41. BTIG analyst Clark Lampen maintained a Buy rating. Unity Software shares closed at $21.41 on Wednesday. See how other analysts view this stock.</li>



<li>JP Morgan raised MercadoLibre Inc (NASDAQ:MELI) price target from $2,650 to $2,800. JP Morgan analyst Marcelo Santos upgraded the stock from Neutral to Overweight. MercadoLibre shares closed at $2,018.18 on Wednesday. See how other analysts view this stock.</li>



<li>Needham cut Neurocrine Biosciences Inc (NASDAQ:NBIX) price target from $187 to $185. Needham analyst Ami Fadia maintained a Buy rating. Neurocrine Biosciences shares closed at $137.44 on Wednesday. See how other analysts view this stock.</li>



<li>HC Wainwright &amp; Co. raised LightPath Technologies Inc (NASDAQ:LPTH) price target from $10 to $15. HC Wainwright &amp; Co. analyst Scott Buck maintained a Buy rating. LightPath Technologies shares closed at $10.27 on Wednesday. See how other analysts view this stock.</li>



<li>BTIG raised the price target for McDonald’s Corp (NYSE:MCD) from $360 to $370. BTIG analyst Peter Saleh maintained a Buy rating. McDonald’s shares closed at $323.21 on Wednesday. See how other analysts view this stock.</li>



<li>Deutsche Bank raised BorgWarner Inc (NYSE:BWA) price target from $46 to $82. Deutsche Bank analyst Edison Yu upgraded the stock from Hold to Buy. BorgWarner shares closed at $66.10 on Wednesday. See how other analysts view this stock.</li>
</ul>



Considering buying MCD stock? Here’s what analysts think: 



<figure class="wp-block-image size-large is-resized"></figure>



Photo via Shutterstock

MELI

TSEM

EATZ

INSP

FTXG

NBIX

Top Wall Street analysts have updated their forecasts for several companies. Notably, BTIG raised McDonald's price target from $360 to $370, maintaining a Buy rating. Other significant changes include Piper Sandler lowering HubSpot's target from $400 to $280, and JP Morgan increasing MercadoLibre's target from $2,650 to $2,800. Analysts also adjusted targets for Ecolab, Tower Semiconductor, Inspire Medical, Unity Software, Neurocrine Biosciences, LightPath Technologies, and BorgWarner, reflecting varied outlooks across the market.

benzinga_article

Unity Software

Mercadolibre

Tower Semicon

AdvisorShares Restaurant ETF

Ecolab

Invesco Food & Beverage ETF

Inspire Medical

First Trust NASDAQ Food & Beverage

McDonald's

Neurocrine Biosciences

McDonald's To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Thursday